Search Results for 'Schizophrenia'

NUI Galway has been awarded a European Research Council Starting Grant of almost €1.5 million over five years from Horizon 2020’s European Research Council, to identify a new biological target for new treatment development of schizophrenia.

Telltale signs in IQ, memory or social intelligence tests could identify if people are at risk of psychosis, according to the findings of a recent study.

A novel rare risk factor linked to mental illnesses such as schizophrenia has been identified by a multi-institutional team led by Professor Sanbing Shen of the Regenerative Medicine Institute (REMEDI) at NUI Galway.